CORRECTION: Propanc Biopharma Announces Strategic Financing Agreement of up to $100 Million with Hexstone Capital
MELBOURNE, Australia, Oct. 15, 2025 (GLOBE NEWSWIRE) -- Propanc Biopharma, Inc. ("Propanc"…
Green Street Brings Its Industry-Leading Public Market Research and REIT Data to Australia – Expanding Global CRE Intelligence
SYDNEY, Oct. 14, 2025 /PRNewswire/ -- Green Street, the leading provider of trusted…
Idorsia successfully completes an upsized offering of shares funding the company to overall profitability
Ad hoc announcement pursuant to Art. 53 LR NOT FOR RELEASE, PUBLICATION,…
New Imprivata Report Finds that Australian Hospitals Save More Than $1.2 Million AUD Annually with Shared-Use Mobile Devices, but Strategic Gaps Still Pose Security and Operational Risk
MELBOURNE, Australia, Oct. 01, 2025 (GLOBE NEWSWIRE) -- Imprivata, a leading provider of…
CLINUVEL to advance novel pharmaceutical formulations in preclinical program
Executive summary first biocompatible pharmaceutical formulations progress to preclinical modelsnew sustained-release drug…
Titomic Appoints Aude Vignelles as President of Asia-Pacific Region
MELBOURNE, Australia, Sept. 26, 2025 /PRNewswire/ -- Titomic Limited (ASX: TTT), a global…
Annature helps accounting firms and company directors manage corporate compliance fees with new product launch
BRISBANE, Australia, Sept. 25, 2025 (GLOBE NEWSWIRE) -- Annature, Australia’s leading provider…
9Spokes Powers Smartpay with its SMB Financial and Customer Insights Platform
AUCKLAND, New Zealand, Sept. 24, 2025 /PRNewswire/ -- 9Spokes, a global data…
Global Roadshows Drive Momentum for the 138th Canton Fair
GUANGZHOU, China, Sept. 19, 2025 /PRNewswire/ -- The global promotion campaign for the…
Skyhawk Therapeutics Announces Positive First Interim Results in Patients from its Phase 1 Clinical Trial of SKY-0515 as a Treatment for Huntington’s Disease
SKY-0515 achieves dose-dependent reductions of mutant huntingtin (mHTT) protein, with 62% lowering…